Clinical evaluation of late outcomes in Dutch childhood cancer survivors: Methodology of the DCCSS LATER 2 study.
Feijen EAM, Teepen JC, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, van der Heiden-van der Loo M, van der Pal HJH, de Vries ACH, Louwerens M, Bresters D, Versluys B, de Ridder H, Veening M, van Leeuwen FE, Grootenhuis M, Maurice-Stam H, van Santen HM, Neggers SJCMM, Pluijm S, den Hartogh J, Ronckers CM, Tissing WJE, Loonen JJ, Kremer LCM.
Feijen EAM, et al. Among authors: versluys b.
Pediatr Blood Cancer. 2023 May;70(5):e30212. doi: 10.1002/pbc.30212. Epub 2023 Jan 18.
Pediatr Blood Cancer. 2023.
PMID: 36651687